The impact of an integrated dual disorder treatment model in detecting substance use disorders in a population with severe mental illness

2009 ◽  
Author(s):  
Deborah A. Vorst ◽  
Randall R. Cottrell
Keyword(s):  
Mental Illness ◽  
Substance Use ◽  
Severe Mental Illness ◽  
Substance Use Disorders ◽  
Treatment Model ◽  
Dual Disorder ◽  
Disorder Treatment ◽  
Integrated Dual Disorder Treatment ◽  
The Impact ◽  
Dual Disorder Treatment

Comorbidity of Physical Disorders Among Patients With Severe Mental Illness With and Without Substance Use Disorders: A Systematic Review and Meta-Analysis

2019 ◽  
Vol 15 (3) ◽  
pp. 192-206 ◽  
Author(s):  
Ifeoma N. Onyeka ◽  
Margrethe Collier Høegh ◽  
Eldbjørg Marie Nåheim Eien ◽  
Bright I. Nwaru ◽  
Ingrid Melle
Keyword(s):  
Systematic Review ◽  
Mental Illness ◽  
Substance Use ◽  
Severe Mental Illness ◽  
Substance Use Disorders ◽  
Meta Analysis ◽  
Physical Disorders

scholarly journals Clinical impact of COVID-19 on people with substance use disorders

2020 ◽  
Author(s):  
G Vallecillo ◽  
R Perelló ◽  
R Güerri ◽  
F Fonseca ◽  
M Torrens
Keyword(s):  
Substance Use ◽  
Substance Use Disorders ◽  
Severe Pneumonia ◽  
Epidemiological Studies ◽  
Urban Hospital ◽  
Increased Risk ◽  
Disorder Treatment ◽  
Low Incidence ◽  
The Impact ◽  
Larger Sample

Abstract Background People with substance use disorders are considered at increased risk of COVID-19 and its more serious complications, however data on the impact of COVID-19 are lacking. The study aimed to describe the clinical characteristics and outcomes of COVID-19 on people with substance use disorders. Methods an observational study was carried out including patients aged ≥ years with COVID-19 pneumonia admitted to an urban hospital during March 12 to June 21,2020. Results Among 2078 patients admitted, 27 (1.3%) were people with substance use disorders: 23(85.2%) were men with a median age of 56.1 + 10.3 years and. The main SUD were alcohol in 18(66.7%) patients, heroine in 6(22.2%) and cocaine in 3(11.1%) and 24(88.8%) patients were on ongoing substance use disorder treatment. One or more comorbidities associated to COVID-19 risk were observed in 18(66.6%) of patients. During a median length of stay of 10 days (IQR:7-19), severe pneumonia developed in 7(25.9%) patients, acute respiratory distress syndrome in 5 (18.5%) and none died. Conclusion Larger sample sizes and sero-epidemiological studies are needed to confirm the low incidence of severe COVID-19 on patients with SUD.

Treating Homeless Clients with Severe Mental Illness and Substance Use Disorders: Costs and Outcomes

2006 ◽  
Vol 42 (4) ◽  
pp. 377-404 ◽  
Author(s):  
Gary A. Morse ◽  
Robert J. Calsyn ◽  
W. Dean Klinkenberg ◽  
Thomas W. Helminiak ◽  
Nancy Wolff ◽  
...  
Keyword(s):  
Mental Illness ◽  
Substance Use ◽  
Severe Mental Illness ◽  
Substance Use Disorders
Sign in / Sign up

Export Citation Format

Share Document